Table 1.
Comparison of the ligand-binding properties of A1R and its heteromers
Radioligand
|
||||||
---|---|---|---|---|---|---|
[3H]DPCPX
|
[3H]NECA
|
[3H]R-PIA
|
||||
KD, nM | Bmax, pmol/mg | KD, nM | Bmax, pmol/mg | KD, nM | Bmax, pmol/mg | |
A1R | 1.3 ± 0.14 | 3.5 ± 0.12 | — | — | — | — |
HA-A1R | 1.2 ± 0.12 | 3.6 ± 0.11 | 3.4 ± 1.2 | 0.11 ± 0.07 | 0.85 ± 0.3 | 0.09 ± 0.02 |
HA-A1R + Myc-P2Y1R | 1.2 ± 0.1 | 1.9 ± 0.05* | 3.5 ± 1.8 | 0.09 ± 0.03 | 3.1 ± 1.7* | 0.08 ± 0.03 |
For an A1R antagonist [3H]DPCPX saturation experiment, 10 μg of membrane protein was incubated with 0.2–10 nM [3H]DPCPX containing 2 units/ml adenosine deaminase, 5 mM MgCl2, and 50 mM Tris-acetate buffer, pH 7.4 for 60 min at 25°C. Nonspecific binding was measured in the presence of 1 μM XAC. For agonist [3H]NECA and [3H]R-PIA saturation experiment, 30–50 μg of membrane proteins was incubated with 2–50 nM radioligands in the same condition described above. The binding of these ligands to Myc-P2Y1R was not detected.
, P < 0.05 (Student's t test, n = 3).